Clicky

Travere Therapeutics, Inc.(TVTX)

Description: At Travere Therapeutics we are in rare for life. We are a biopharmaceutical company that comes together every day to help patients, families and caregivers of all backgrounds as they navigate life with a rare disease. On this path, we know the need for treatment options is urgent – that is why our global team works with the rare disease community to identify, develop and deliver life-changing therapies. In pursuit of this mission, we continuously seek to understand the diverse perspectives of rare patients and to courageously forge new paths to make a difference in their lives and provide hope – today and tomorrow.


Keywords: Medicine Biopharmaceutical Kidney Disease Medical Genetics Dystrophy Muscular Dystrophy Duchenne Muscular Dystrophy Spinal Muscular Atrophy Genetic Genealogy Caregiver Focal Segmental Glomerulosclerosis Channelopathies Glomerulosclerosis

Home Page: www.travere.com

TVTX Technical Analysis

3611 Valley Centre Drive
San Diego, CA 92130
United States
Phone: 888 969 7879


Officers

Name Title
Dr. Eric M. Dube Ph.D. Pres, CEO & Director
Ms. Elizabeth E. Reed Sr. VP, Gen. Counsel & Corp. Sec.
Dr. William E. Rote Ph.D. Sr. VP of R&D
Dr. Noah L. Rosenberg M.D. Exec. Advisor
Mr. Christopher Cline C.F.A., CFA Chief Financial Officer
Ms. Sandra Calvin VP, Corp. Controller & Principal Accounting Officer
Ms. Charlotte Smith Sr. VP of Public Affairs
Mr. Casey Logan Sr. VP of Corp. & Bus. Devel.
Ms. Angela Giannantonio Sr. VP of HR
Mr. Peter Heerma Chief Commercial Officer

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 11.939
Price-to-Sales TTM: 5.5633
IPO Date: 2012-11-08
Fiscal Year End: December
Full Time Employees: 310
Back to stocks